Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT06649318
Eligibility Criteria:
Inclusion Criteria:
* Patients older than 18 years and younger than 65 years who will be operated under total intravenous anesthesia
* ASAI-II status
Exclusion Criteria:
* Patients for whom Intensive Care Unit (ICU) indication is foreseen
* Chronic obstructive pulmonary disease,
* A personal or family history of malignant hyperthermia,
* Alcohol or drug addiction,
* History of liver or kidney disease,
* With coronary artery disease or heart failure,
* Significant anemia or hemoglobinopathy,
* Hypotension, hypovolemia, sepsis,
* Unregulated diabetic patients,
* Female patients who are pregnant or lactating.
* Allergic to propofol and halogens
* Patients on gabapentinoids
* Those with a history of head trauma
* Those with neurological disorders
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06649318
Study Brief:
Protocol Section:
NCT06649318